Treatment of Capd Peritonitis with Oral Trimethoprim/Sulfamethoxazole and Intraperitoneal Aminoglycoside Combination

Abstract

Get full access to this article

View all access options for this article.

References

Uttley

A.H.C.

, Collins

C.H.

, Naidoo

, George

R.C.

Vanco-mycin-resistant enterococci.

Lancet 1988; 1: 57–8.

Edmond

M.B.

, Wenzel

R.P.

, Pascule

A.W.

Vancomycin-resistant Staphylococcus aureus: perspectives on measures needed for control.

Ann Intern Med 1996; 124: 329–34.

Keane

W.F.

, Alexander

S.R.

, Bailie

G.R.

, Boeschoten

, Gokal

, Golper

T.A.

Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update.

Perit Dial Int 1996; 16: 557–73.

Ersoy

E.F.

, Sezer

, Sarikaya

, Süleymanlar

, Yakupoglu

Treatment of CAPD peritonitis with intraperitoneal ampicillin/sulbactam-aminoglycoside combination.

Perit Dial Int 1998; 18: 233–4.

Lai

M.N.

, Kao

M.T.

, Chen

C.C.

, Cheung

S.Y.

, Chung

W.K.

Intraperitoneal once-daily dose of cefazolin and gentamicin for treating CAPD peritonitis.

Perit Dial Int 1997; 17: 87–9.

Vas

, Bargman

, Oreopoulos

D.G.

Treatment in PD patients of peritonitis caused by gram-positive organisms with single daily dose of antibiotics.

Perit Dial Int 1997; 17: 91–4.